Review Article

Systematic Review of Compound Danshen Dropping Pill: A Chinese Patent Medicine for Acute Myocardial Infarction

Table 3

Characteristics of included studies.

IDSample size
( / )
Age
(y, / )
Diagnostic
criteria of AMI
Type of
AMI
InterventionControlDuration of
treatment
Follow upOutcomesBaseline report

Li et al. 2011 [19]500 (252/248)60.10 ± 9.60/
56.70 ± 7.80
Not specified STEMI CDDP 10 pills tid + CT
(the same as control)
CT (western medicines
+ PCI)
30 days 30 days All-cause mortality, shock,
arrhythmia, LVEF%, HF,
angina, myocardial enzyme.
Yes
Lin 2011 [33]90 (46/44)43–75/36–72ACC/AHA
2004
Unclear CDDP 10 pills tid + CT (the same as control)CT (western medicines) 6 weeks 6 weeks LVEF%, WBC, CRP,
Chinese symptoms.
Yes
(narrative only)
Ma 2010 [35] 163 (78/85)62.55 ± 11.95/
66.02 ± 11.40
Not specified STEMI CDDP 10 pills tid + CT (the same as control) CT (western medicines or
plus PCI/thrombolysis)
1 month 3 monthsAll-cause mortality, IL-6,
cardiac mortality, hs-CRP,
MACEs, MMP-9, TNF-a.
Yes
Li et al. 2010 [36]63 (42/21)58.40 ± 11.60 Not specified Unclear CDDP 10 pills tid + CT (the same as control)Placebo + CT (western
Medicines + thrombolysis).
4 months4 months Cardiac mortality, LVEF%,
readmission, QOL, RMI,
HF, angina, adverse events.
Yes
(narrative only)
Guo et al. 2010 [20]136 (76/60)55.60 ± 12.5/
51.80 ± 13.60
WHOUnclear CDDP 10 pills tid + CT (the same as control) CT (western medicines
+ thrombolysis)
4 weeks4 weeks All-cause mortality, shock,
HF, recanalization, angina,
myocardial enzyme.
Yes
(narrative only)
Xu and Wang 2007 [21]218 (66/72/80) 36–75/37–78
/32–79
WHO With
Q-wave
CDDP 10 pills tid d1-60, then 5 pills tid + CT (the same as control) Propranolol 10 15 mg tid + CT (no detail);
CT (no detail)
12 months 12 months All-cause mortality, RMI,
cardiac mortality, HF,
arrhythmia, LVEF%.
Yes
(narrative only)
Mei et al. 2006 [34]45 (23/22)56.11 ± 11.13Not specified Unclear CDDP 10 pills tid + CT (the same as control)CT (western medicines) 6 months 6 months LVEF%, SV, CO Unclear

Notes: CT: conventional therapy; HF: heart failure; AHA: American heart Association; ACC: American College of Cardiology; CRP: C-reactive protein; hs-CRP: high sensitive C-reactive protein; WBC: white blood cell; MACEs: major adverse cardiac events; WHO: World Health Organization; TNF-α: tumor necrosis factor-alpha; MMP-9: matrix metalloproteinase-9; IL-6: interleukin-6; SV: stroke volume; CO: cardiac output; tid: three times a day.